Toma-Dasu I - Search Results

1

Dosimetric comparison between intra-cavitary breast brachytherapy techniques for accelerated partial breast irradiation and a novel stereotactic radiotherapy device for breast cancer: GammaPod™.

Ödén J, Toma-Dasu I, Yu CX, Feigenberg SJ, Regine WF, Mutaf YD. Ödén J, et al. Phys Med Biol. 2013 Jul 7;58(13):4409-21. doi: 10.1088/0031-9155/58/13/4409. Epub 2013 Jun 6. Phys Med Biol. 2013. PMID: 23743718

2

Should single or distributed parameters be used to explain the steepness of tumour control probability curves?

Daşu A, Toma-Daşu I, Fowler JF. Daşu A, et al. Phys Med Biol. 2003 Feb 7;48(3):387-97. doi: 10.1088/0031-9155/48/3/308. Phys Med Biol. 2003. PMID: 12608614

3

The influence of dose heterogeneity on tumour control probability in fractionated radiation therapy.

Wiklund K, Toma-Dasu I, Lind BK. Wiklund K, et al. Phys Med Biol. 2011 Dec 7;56(23):7585-600. doi: 10.1088/0031-9155/56/23/016. Phys Med Biol. 2011. PMID: 22086189

4

Treatment fractionation for stereotactic radiotherapy of lung tumours: a modelling study of the influence of chronic and acute hypoxia on tumour control probability.

Lindblom E, Antonovic L, Dasu A, Lax I, Wersäll P, Toma-Dasu I. Lindblom E, et al. Radiat Oncol. 2014 Jun 30;9:149. doi: 10.1186/1748-717X-9-149. Radiat Oncol. 2014. PMID: 24974778 Free PMC article.

5

Dosimetric evaluation of manually and inversely optimized treatment planning for high dose rate brachytherapy of cervical cancer.

Palmqvist T, Dybdahl Wanderås A, Langeland Marthinsen AB, Sundset M, Langdal I, Danielsen S, Toma-Dasu I. Palmqvist T, et al. Acta Oncol. 2014 Aug;53(8):1012-8. doi: 10.3109/0284186X.2014.928829. Epub 2014 Jun 30. Acta Oncol. 2014. PMID: 24975370

6

Disregarding RBE variation in treatment plan comparison may lead to bias in favor of proton plans.

Wedenberg M, Toma-Dasu I. Wedenberg M, et al. Med Phys. 2014 Sep;41(9):091706. doi: 10.1118/1.4892930. Med Phys. 2014. PMID: 25186381

7

Evaluating tumor response of non-small cell lung cancer patients with ¹⁸F-fludeoxyglucose positron emission tomography: potential for treatment individualization.

Toma-Dasu I, Uhrdin J, Lazzeroni M, Carvalho S, van Elmpt W, Lambin P, Dasu A. Toma-Dasu I, et al. Int J Radiat Oncol Biol Phys. 2015 Feb 1;91(2):376-84. doi: 10.1016/j.ijrobp.2014.10.012. Int J Radiat Oncol Biol Phys. 2015. PMID: 25636761 Clinical Trial.

8

Radiobiological treatment planning evaluation of inverse planning simulated annealing for cervical cancer high-dose-rate brachytherapy.

Palmqvist T, Dos S Matias L, Marthinsen AB, Sundset M, Wanderås AD, Danielsen S, Toma-Dasu I. Palmqvist T, et al. Anticancer Res. 2015 Feb;35(2):935-9. Anticancer Res. 2015. PMID: 25667477

9

Relative clinical effectiveness of carbon ion radiotherapy: theoretical modelling for H&N tumours.

Antonovic L, Dasu A, Furusawa Y, Toma-Dasu I. Antonovic L, et al. J Radiat Res. 2015 Jul;56(4):639-45. doi: 10.1093/jrr/rrv016. Epub 2015 Apr 8. J Radiat Res. 2015. PMID: 25858182 Free PMC article.

10

Dosimetric and Radiobiological Evaluation of Hybrid Inverse Planning and Optimization for Cervical Cancer Brachytherapy.

Matias Ldos S, Palmqvist T, Wolke J, Nilsson J, Beskow C, Maphossa AM, Toma-Dasu I. Matias Ldos S, et al. Anticancer Res. 2015 Nov;35(11):6091-6. Anticancer Res. 2015. PMID: 26504034

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

114 results

Search Page

Filters